Company intelligence / Profile preview

Dreampath Diagnostics

Strasbourg, Grand Est, Francedreampathdx.net ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

Dreampath Diagnostics has commercialized a suite of automated systems—Fina, Crystal, and Hydra—that have been adopted by over 500 laboratories in more than 40 countries. These systems are credited with significant improvements in workflow efficiency, error reduction, patient safety, and cost savings in anatomic pathology labs. Real-world deployments report up to 91% time savings in certain processes and elimination of manual touchpoints that previously led to lost samples or errors.

Industry: Pathology

Partnerships

Cardiff University Health Board (UK)Cleveland Clinic (US)Academic Medical Center BostonCardinal HealthLaunch Diagnostics

Beyond the preview

Go deeper on Dreampath Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dreampath Diagnostics.

Explore the full profile